Institution
Betsi Cadwaladr University Health Board
Healthcare•Bangor, United Kingdom•
About: Betsi Cadwaladr University Health Board is a healthcare organization based out in Bangor, United Kingdom. It is known for research contribution in the topics: Population & Mental health. The organization has 655 authors who have published 640 publications receiving 11142 citations. The organization is also known as: Betsi Cadwaladr Local Health Board & BCUHB.
Topics: Population, Mental health, Randomized controlled trial, Health care, Psychological intervention
Papers published on a yearly basis
Papers
More filters
••
TL;DR: This is the first review encompassing many cancer types, and it is demonstrated that efforts to expedite the diagnosis of symptomatic cancer are likely to have benefits for patients in terms of improved survival, earlier-stage diagnosis and improved quality of life, although these benefits vary between cancers.
Abstract: It is unclear whether more timely cancer diagnosis brings favourable outcomes, with much of the previous evidence, in some cancers, being equivocal. We set out to determine whether there is an association between time to diagnosis, treatment and clinical outcomes, across all cancers for symptomatic presentations. Systematic review of the literature and narrative synthesis. We included 177 articles reporting 209 studies. These studies varied in study design, the time intervals assessed and the outcomes reported. Study quality was variable, with a small number of higher-quality studies. Heterogeneity precluded definitive findings. The cancers with more reports of an association between shorter times to diagnosis and more favourable outcomes were breast, colorectal, head and neck, testicular and melanoma. This is the first review encompassing many cancer types, and we have demonstrated those cancers in which more evidence of an association between shorter times to diagnosis and more favourable outcomes exists, and where it is lacking. We believe that it is reasonable to assume that efforts to expedite the diagnosis of symptomatic cancer are likely to have benefits for patients in terms of improved survival, earlier-stage diagnosis and improved quality of life, although these benefits vary between cancers.
657 citations
••
TL;DR: Investigating gray and white matter abnormalities in delusional infestation shows that structural changes in prefrontal, temporal, insular, cingulate and striatal brain regions are associated with DI, supporting a neurobiological model of disrupted prefrontal control over somato-sensory representations.
Abstract: Little is known about the neural basis of delusional infestation (DI), the delusional belief to be infested with pathogens. Case series and the response to anti-dopaminergic medication indicate disruptions in dopaminergic neurotransmission in the striatum (caudate, putamen), but did not allow for population-based inference. Here, we report the first whole-brain structural neuroimaging study to investigate gray and white matter abnormalities in DI compared to controls. In this study, we used structural magnetic resonance imaging and voxel-based morphometry to investigate gray and white matter volume in 16 DI patients and 16 matched healthy controls. Lower gray matter volume in DI patients compared to controls was found in left medial, lateral and right superior frontal cortices, left anterior cingulate cortex, bilateral insula, left thalamus, right striatal areas and in lateral and medial temporal cortical regions (p<0.05, cluster-corrected). Higher white matter volume in DI patients compared to controls was found in right middle cingulate, left frontal opercular and bilateral striatal regions (p<0.05, cluster-corrected). This study shows that structural changes in prefrontal, temporal, insular, cingulate and striatal brain regions are associated with DI, supporting a neurobiological model of disrupted prefrontal control over somato-sensory representations.
613 citations
••
University of Bristol1, Imperial College London2, University of the West of England3, King's College London4, University of Southampton5, University of Leeds6, University of Surrey7, University of Glasgow8, University of Regensburg9, Duke University10, Betsi Cadwaladr University Health Board11, University College London Hospitals NHS Foundation Trust12, University of Oxford13
TL;DR: These British Association for Psychopharmacology guidelines are designed to address this problem by providing an accessible up-to-date and evidence-based outline of the major issues, especially those relating to reliable diagnosis and appropriate treatment.
Abstract: Sleep disorders are common in the general population and even more so in clinical practice, yet are relatively poorly understood by doctors and other health care practitioners. These British Association for Psychopharmacology guidelines are designed to address this problem by providing an accessible up-to-date and evidence-based outline of the major issues, especially those relating to reliable diagnosis and appropriate treatment. A consensus meeting was held in London in May 2009. Those invited to attend included BAP members, representative clinicians with a strong interest in sleep disorders and recognized experts and advocates in the field, including a representative from mainland Europe and the USA. Presenters were asked to provide a review of the literature and identification of the standard of evidence in their area, with an emphasis on meta-analyses, systematic reviews and randomized controlled trials where available, plus updates on current clinical practice. Each presentation was followed by discussion, aimed to reach consensus where the evidence and/or clinical experience was considered adequate or otherwise to flag the area as a direction for future research. A draft of the proceedings was then circulated to all participants for comment. Key subsequent publications were added by the writer and speakers at draft stage. All comments were incorporated as far as possible in the final document, which represents the views of all participants although the authors take final responsibility for the document.
503 citations
••
TL;DR: In a proof-of-concept study, eight patients with depression learned to upregulate brain areas involved in the generation of positive emotions during four neurofeedback sessions, and their clinical symptoms improved significantly.
Abstract: Many patients show no or incomplete responses to current pharmacological or psychological therapies for depression. Here we explored the feasibility of a new brain self-regulation technique that integrates psychological and neurobiological approaches through neurofeedback with functional magnetic resonance imaging (fMRI). In a proof-of-concept study, eight patients with depression learned to upregulate brain areas involved in the generation of positive emotions (such as the ventrolateral prefrontal cortex (VLPFC) and insula) during four neurofeedback sessions. Their clinical symptoms, as assessed with the 17-item Hamilton Rating Scale for Depression (HDRS), improved significantly. A control group that underwent a training procedure with the same cognitive strategies but without neurofeedback did not improve clinically. Randomised blinded clinical trials are now needed to exclude possible placebo effects and to determine whether fMRI-based neurofeedback might become a useful adjunct to current therapies for depression.
374 citations
••
TL;DR: The findings support the view that EF impairments are evident in PD, and the clinical significance of the cognitive abnormalities reported has yet to be clarified.
Abstract: Impairment of executive function (EF) is commonly reported as a feature of PD. However, the exact pattern of executive impairment remains unclear. Also, there is an ongoing discussion surrounding the definition and conceptualization of EF, which might affect the clarity of research evidence on cognition in PD. The aim of this systematic review was to describe the pattern of executive impairment in early-stage PD emerging from the research literature and to identify critical issues for improving consistency in this field. The PsychInfo, MEDLINE, Science Direct, CINAHL, and Cochrane Library databases were searched using the term "Parkinson's disease" combined with each of 14 cognitive abilities defined as representing aspects of EF. The review was limited to studies that investigated EF as the central variable in early-stage, nondemented PD patients. The review identified 33 studies of EF that were operationalized in terms of 30 abilities tested by 60 measures and variously interpreted. Many measures were used only once, so only a small part of the available research evidence could be synthesized in the meta-analysis. The meta-analysis was undertaken using data from five commonly used tests of EF drawn from 18 studies. This revealed consistent evidence for cognitive difficulties across all five EF tests. Research on EF in PD is characterized by a considerable lack of clarity with regard to measure selection and interpretation. The findings support the view that EF impairments are evident in PD. However, the clinical significance of the cognitive abnormalities reported has yet to be clarified.
332 citations
Authors
Showing all 656 results
Name | H-index | Papers | Citations |
---|---|---|---|
Sang Cheol Bae | 80 | 582 | 28575 |
David Edmund Johannes Linden | 74 | 361 | 18787 |
Linda Clare | 70 | 367 | 17695 |
Peter J. Maddison | 59 | 192 | 16129 |
Richard Evans | 48 | 306 | 10513 |
David Healy | 47 | 254 | 9882 |
Dyfrig A. Hughes | 47 | 255 | 8328 |
David Markland | 43 | 87 | 10028 |
Alexander Vincent Anstey | 42 | 168 | 6705 |
Stephen Platt | 42 | 122 | 8526 |
Sanjay K. Agarwal | 39 | 324 | 17418 |
Jeanette M. Thom | 33 | 98 | 3778 |
Peter Lepping | 29 | 102 | 3021 |
Jeremy Jones | 29 | 70 | 3401 |
Pasquale F. Innominato | 28 | 94 | 2927 |